Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Stifel Nicolaus Healthcare Conference
ROCKVILLE, Maryland – September 14, 2010-- Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the Stifel Nicolaus 2010 Healthcare Conference will be webcast and may be accessed atwww.hgsi.com.
A member of Human Genome Sciences’ senior management team will present a corporate overview on Friday, September 17, 2010, at 11:30 AM Eastern. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.
About Human Genome Sciences
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.
For more information about HGS, please visit the Company’s web site at www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
or by calling HGS at (877) 822-8472.
HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc.
# # #
Media Contact:
Jerry Parrott
Vice President, Corporate Communications
301-315-2777
Investor Contact:
Claudine Prowse, Ph.D.
Executive Director, Investor Relations
301-315-1785
Peter Vozzo
Senior Director, Investor Relations
301-251-6003
Press Contact:
Jerry Parrott
301-315-2777
http://www.hgsi.com
**d**f*@h**i.com
Email partially hidden to block spam. Please use the contact form here.
More User Press Releases
- HUMAN GENOME SCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2009 FINANCIAL RESULTS AND KEY DEVELOPMENTS
- HUMAN GENOME SCIENCES APPOINTS COLIN GODDARD, Ph.D., TO ITS BOARD OF DIRECTORS
- HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE FDA EXTENSION OF BENLYSTA® PDUFA TARGET DATE TO MARCH 10, 2011
- HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE VOTE OF FDA ADVISORY COMMITTEE TO RECOMMEND APPROVAL OF BENLYSTA® FOR SYSTEMI
- HUMAN GENOME SCIENCES ANNOUNCES THIRD QUARTER 2010 FINANCIAL RESULTS AND KEY DEVELOPMENTS
- HUMAN GENOME SCIENCES RECEIVES COMPLETE RESPONSE LETTER FROM FDA ON ZALBIN™ BLA FOR CHRONIC HEPATITIS C
- HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT JMP SECURITIES HEALTHCARE CONFERENCE
- Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Ubs Healthcare Conference
- Human Genome Sciences Invites Investors to listen to Webcast of Presentation at Robert W. Baird Health Care Conference
- HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT MORGAN STANLEY HEALTHCARE CONFERENCE
Like this site on Facebook
Distribute Press Release
- Post press release to 50+ free press release websites.
- Send to 100+ online publications.
- Effortlessly publish all your press releases with our automated pickup and submission service.
User login
Search
Bookmark/Search this post
Primary Menu
- News by Region
- Business
- List of Industries
- Technology
- Aerospace & Defense
- Agriculture & Forestry
- Arts
- Automotive
- Business Services
- Chemicals
- Construction & Maintenance
- Consumer Goods
- Education
- Electrical & Electronics
- Energy
- Entertainment
- Food & Related Products
- General Business
- Government
- Healthcare
- Heavy Industry
- Home
- Industrial Goods & Services
- Industrial Materials
- Medical
- Mining & Drilling
- Publishing & Printing
- Retail
- Society
- Sports
- Supermarkets
- Telecommunications
- Textiles & Nonwovens
- Transportation & Logistics
- Travel & Hospitality
- Wholesale
